A global population of patients with prediabetes that is three times the size of those who already have Type 2 diabetes has led to intense competition between drug makers to launch drugs to treat the disease, according to a new report.
Some patients with Type 2 diabetes taking drugs to lower blood sugar may experience a greater drop than is healthy for them even though their disease may not be under control, according to a new study.
Boulder Brands, Inc. announced it had acquired 80% of GlucoBrands, owner of Level Life Foods. Based in Colorado, Level is a growing company, approaching $1 million in sales that provides products to help in the daily management of diabetes.
The Indian generic drug maker announced the approval of repaglinide tablets in the 1-mg and 2-mg strengths, which are used in combination with diet and exercise to improve blood-sugar control in patients with Type 2 diabetes.